Skip Navigation



British Medical Bulletin Advance Access published online on November 8, 2009
British Medical Bulletin, doi:10.1093/bmb/ldp032
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/1/79    most recent
ldp032v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pattni, S.
Right arrow Articles by Walters, J. R.F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pattni, S.
Right arrow Articles by Walters, J. R.F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Recent advances in the understanding of bile acid malabsorption

Sanjeev Pattni{dagger},{ddagger} and Julian R.F. Walters{dagger},{ddagger},*

{dagger} Department of Gastroenterology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK
{ddagger} Section of Hepatology and Gastroenterology, Imperial College, London, UK

* Correspondence to: Consultant Gastroenterologist, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London W12 0HS, UK. E-mail: julian.walters{at}imperial.ac.uk

Introduction: Bile acid malabsorption (BAM) is a syndrome of chronic watery diarrhoea with excess faecal bile acids. Disruption of the enterohepatic circulation of bile acids following surgical resection is a common cause of BAM. The condition is easily diagnosed by the selenium homocholic acid taurine (SeHCAT) test and responds to bile acid sequestrants. Idiopathic BAM (IBAM, primary bile acid diarrhoea) is the condition where no definitive cause for low SeHCAT retention can be identified.

Sources of data: Review of PubMed and major journals.

Areas of agreement: Evidence is accumulating that BAM is more prevalent than first thought. Management of chronic diarrhoea involves excluding secondary causes. Treatment of the condition is with bile acid binders.

Areas of controversy: SeHCAT testing is not widely performed, limiting awareness of how common this condition can be. The underlying mechanism for IBAM has been unclear.

Growing points: Increasing awareness of the condition is important. Alternative mechanisms of IBAM have been suggested which involve an increased bile acid pool size and reduced negative feedback regulation of bile acid synthesis by FGF19. New sequestrants are available.

Areas timely for developing research: Further research into the precise mechanism of IBAM is needed. Improvements in the recognition of the condition and optimization of treatment are required.

Keywords: bile acid malabsorption • diarrhoea • SeHCAT • mechanisms

Accepted for publication July 10, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.